MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0010603
Apicem Pharmaceuticals Private Limited
Apicem Pharmaceuticals Private Limited - chemicals in Bangalore, Karnataka, India. Directors, charges & compliance details.
Revenue · FY 2024
₹28.99 Lakh
▲ 42% YoY
Net profit · FY 2024
₹60,049
Net margin 2.1%
EBITDA · FY 2024
₹93,673
EBITDA margin 3.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Apicem Pharmaceuticals Private Limited
Data last updated:
Apicem Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the basic chemical manufacturing segment of the chemicals sector. It was incorporated on 02 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2020PTC191552.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gopal Naik Vankadothu and Sravanthi Vankudoth.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.99 Lakh, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹60,049 (net margin 2.1%) and EBITDA of ₹93,673 (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
Apicem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0010603).
Company details
CIN U24100KA2020PTC191552
Registration Number 191552
Incorporation Date 02 November 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0010603
CIN history
Apicem Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100TG2020PTC145459. The current CIN is U24100KA2020PTC191552, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100KA2020PTC191552 | Current |
| U24100TG2020PTC145459 | Previous |
Recognitions & Rankings of Apicem Pharmaceuticals
Contact details
Apicem Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressH No – 108 Sai Nivasa Apartments, Near Nanjappa Circle Nandanvanam Layout, Bangalore, Karnataka, India – 560097
- IndustryChemicals, Basic Chemical, Manufacturing
Comprehensive company report
Apicem Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Apicem Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Apicem Pharmaceuticals Private Limited, buy the company report.
Financials of Apicem Pharmaceuticals Private Limited
FY 2025 filings availableApicem Pharmaceuticals Private Limited reported revenue of ₹28.99 Lakh (up 42% YoY) for FY 2024.
Revenue · FY 2024
₹28.99 Lakh ▲ 42%
Net profit · FY 2024
₹60,049 margin 2.1%
EBITDA · FY 2024
₹93,673 margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 217%
3 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 62% over three years, including 42% growth in the latest year. EBITDA rose 217% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹93,673 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹60,049 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.2% | |||
| Net Profit Margin | 2.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Apicem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Apicem Pharmaceuticals Private Limited
Apicem Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopal Naik Vankadothu | Director | 31 May 2024 | 2 Years 4 Months | Current |
| Sravanthi Vankudoth Also directs: Newloris Pharmaceuticals Private Limited | Director | 02 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Apicem Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Litsa Pharmaceuticals Private Limited | ₹29.17 Lakh (FY 2024) | -10.0% | Varanasi, Uttar Pradesh, India | |||
| Hygitech Solutions Private Limited | ₹29.03 Lakh (FY 2024) | Gmc, Assam, India | ||||
| Adn Pharmaceuticals Private Limited | ₹29 Lakh (FY 2022) | -29.0% | Pune, Maharashtra, India | |||
| Apicem Pharmaceuticals Private Limitedthis company | ₹28.99 Lakh (FY 2024) | ₹60,049 | 2.1% | 42.0% | Bangalore, Karnataka, India | |
| Paeon Pharmaceuticals Private Limited | ₹28.94 Lakh (FY 2019) | -6.0% | Lashkar, Madhya Pradesh, India | |||
| Arlon Pharmaceuticals Private Limited | ₹28.9 Lakh (FY 2024) | 161.0% | Pune, Maharashtra, India |
To see the full peer comparison of Apicem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Apicem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apicem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Apicem Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Apicem Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Gopal Naik Vankadothu was appointed as Director on 31 May 2024.
AGM
Apicem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apicem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Gopal Naik Vankadothu was appointed as Director.
Ceased
Tirumala Korra ceased to be Director.
Appointed
Sravanthi Vankudoth was appointed as Director.
Incorporation
02 Nov 2020
Apicem Pharmaceuticals Private Limited was registered on 02 Nov 2020 with Roc Bangalore & aged 5 years 11 months as per MCA records.
Frequently asked questions
Apicem Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in basic chemical, within the chemicals industry. It was incorporated on 02 November 2020 (6+ years old) and is registered under CIN U24100KA2020PTC191552.
Apicem Pharmaceuticals has 2 current directors:
- Gopal Naik Vankadothu - Director
- Sravanthi Vankudoth - Director
The latest financial statements of Apicem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Apicem Pharmaceuticals is U24100KA2020PTC191552. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apicem Pharmaceuticals was incorporated on 02 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Apicem Pharmaceuticals by revenue are Litsa Pharmaceuticals Private Limited, Hygitech Solutions Private Limited, Adn Pharmaceuticals Private Limited, Paeon Pharmaceuticals Private Limited, Arlon Pharmaceuticals Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Gopal Naik Vankadothu was appointed as Director on 31 May 2024. Tirumala Korra ceased to be Director on 31 May 2024. Sravanthi Vankudoth was appointed as Director on 02 Nov 2020.
Yes, Apicem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0010603).
The registered office of Apicem Pharmaceuticals is at H No – 108 Sai Nivasa Apartments, Near Nanjappa Circle Nandanvanam Layout, Bangalore, Karnataka, India – 560097.
Apicem Pharmaceuticals operates in the chemicals industry, in the basic chemical segment.
Apicem Pharmaceuticals can be reached at its registered office: H No – 108 Sai Nivasa Apartments, Near Nanjappa Circle Nandanvanam Layout, Bangalore, Karnataka, India – 560097.